Correlation Between Recursion Pharmaceuticals and Lyra Therapeutics
Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and Lyra Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and Lyra Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Recursion Pharmaceuticals and Lyra Therapeutics, you can compare the effects of market volatilities on Recursion Pharmaceuticals and Lyra Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of Lyra Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and Lyra Therapeutics.
Diversification Opportunities for Recursion Pharmaceuticals and Lyra Therapeutics
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Recursion and Lyra is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and Lyra Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyra Therapeutics and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with Lyra Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyra Therapeutics has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and Lyra Therapeutics go up and down completely randomly.
Pair Corralation between Recursion Pharmaceuticals and Lyra Therapeutics
Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 0.9 times more return on investment than Lyra Therapeutics. However, Recursion Pharmaceuticals is 1.11 times less risky than Lyra Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Lyra Therapeutics is currently generating about -0.05 per unit of risk. If you would invest 717.00 in Recursion Pharmaceuticals on September 26, 2024 and sell it today you would earn a total of 7.00 from holding Recursion Pharmaceuticals or generate 0.98% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Recursion Pharmaceuticals vs. Lyra Therapeutics
Performance |
| Timeline |
| Recursion Pharmaceuticals |
| Lyra Therapeutics |
Recursion Pharmaceuticals and Lyra Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Recursion Pharmaceuticals and Lyra Therapeutics
The main advantage of trading using opposite Recursion Pharmaceuticals and Lyra Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, Lyra Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyra Therapeutics will offset losses from the drop in Lyra Therapeutics' long position.| Recursion Pharmaceuticals vs. Absci Corp | Recursion Pharmaceuticals vs. Affimed NV | Recursion Pharmaceuticals vs. Sana Biotechnology | Recursion Pharmaceuticals vs. Relay Therapeutics |
| Lyra Therapeutics vs. Fate Therapeutics | Lyra Therapeutics vs. Caribou Biosciences | Lyra Therapeutics vs. Karyopharm Therapeutics | Lyra Therapeutics vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |